Computerized Assessment of Psychosis Risk
| Autor: | Philip R. Corlett, Gregory P. Strauss, Scott W. Woods, James M. Gold, Steven M. Silverstein, Albert R. Powers, Jason Schiffman, Shuo Chen, Trevor F. Williams, Elaine F. Walker, Lauren M. Ellman, Richard E. Zinbarg, James A. Waltz, Joshua Kenney, Vijay A. Mittal |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Psychosis
Psychosis risk precision medicine Article computerized assessment law.invention Prodrome law Intervention (counseling) medicine psychosis business.industry computational psychiatry behavioral tasks medicine.disease Precision medicine clinical high-risk prodrome Test (assessment) schizophrenia Calculator Schizophrenia risk screening risk calculator business Clinical psychology |
| Zdroj: | Journal of psychiatry and brain science |
| ISSN: | 2398-385X |
| Popis: | Early detection and intervention with young people at clinical high risk (CHR) for psychosis is critical for prevention efforts focused on altering the trajectory of psychosis. Early CHR research largely focused on validating clinical interviews for detecting at-risk individuals; however, this approach has limitations related to: (1) specificity (i.e., only 20% of CHR individuals convert to psychosis) and (2) the expertise and training needed to administer these interviews is limited. The purpose of our study is to develop the computerized assessment of psychosis risk (CAPR) battery, consisting of behavioral tasks that require minimal training to administer, can be administered online, and are tied to the neurobiological systems and computational mechanisms implicated in psychosis. The aims of our study are as follows: (1A) to develop a psychosis-risk calculator through the application of machine learning (ML) methods to the measures from the CAPR battery, (1B) evaluate group differences on the risk calculator score and test the hypothesis that the risk calculator score of the CHR group will differ from help-seeking and healthy controls, (1C) evaluate how baseline CAPR battery performance relates to symptomatic outcome two years later (i.e., conversion and symptomatic worsening). These aims will be explored in 500 CHR participants, 500 help-seeking individuals, and 500 healthy controls across the study sites. This project will provide a next-generation CHR battery, tied to illness mechanisms and powered by cutting-edge computational methods that can be used to facilitate the earliest possible detection of psychosis risk. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|